Exchange: NASDAQ·Updated 06:33 PM EDT
PCSA logo

PCSA Processa Pharmaceuticals Inc

$1.55
$0.155
(8.76%)
Today
Closed $1.62
$0.065
(4.03%)
After Hours
Reported EarningsAug 7
Mkt Cap$4.95M
Vol46,328.00

About PCSA

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.
35

Bearish Sentiment

How do you feel about PCSA?

Jwa68
$PCSA Over the last 5 years, Processa Pharmaceuticals Inc. (PCSA) stock has declined by approximately -99.96%. That is the legacy left by David Young and Patrick Lin. Not sure how either sleep at night knowing what they directly oversaw and did to shareholders. And yet they paid themselves nearly $2M a year on salaries across the management team and made out well in the recent merger transaction leaving existing Processa shareholders with under 1% of the new company. Character counts...
3
Jwa68
$PCSA Be interesting to see what happens with 300M shares being registered and now able to be sold, plus the still ongoing shareholder lawsuit.
2
ony2k
$PCSA Up 25% today? What gives? These thieves trying to collar more unsupecting retail investors? Looks that way to me. I'll take it because I refuse to sell for a loss. Any chance it hits my avg, 7.46$ before hell freezes over?
1
Jwa68
$PCSA New all time low. Quite an unfortunate legacy left by Processa and its management.
1
chicharrotrading
$PCSA $NDRA 🔥 today's watchlist — 1 micro/nano-cap + 1 micro/nano-floater covered below. $PCSA (#17) 🚀 strong momentum, ⚠️ elevated risk | Healthcare/Biotechnology ($5.3M) 🔦 Chart flags a recent MACD/Signal crossover — 🏭 FDA decision cycles Patent-cliff timing Health-policy debates — 🌍 Trade policy Export controls Currency fluctuations Regional stability — 📰 Processa Pharmaceuticals Proposes Reverse Stock Split Following Merger with Vidya Therapeutics (Kalkine Media) $NDRA (#10) ⚠️ elevated risk | Healthcare/Diagnostics & Research ($7.7M) — Float 1.4M sh shares 📊 continuation structure characterised by lower highs and lower lows — 🔦 Chart flags a recent test of the reference support level — 🏭 FDA decision cycles Patent-cliff timing Health-policy debates — 🌍 Central-bank policy stance Interest-rate expectations Risk appetite — 📰 187,169 warrant shares are part of ASP Isotopes' stake in ENDRA Life Sciences (NDRA). (Stock Titan)
GJ_Rockabilt
$PCSA No thanks, I think I'll stick with my $BFRI recent FDA Approval. I'm not Buying it, on this PCSA uptick, PreMarket. New Officers want new free Shares?

Advertisement|Remove ads.